Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix) (RECON)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
CorMatrix
ClinicalTrials.gov Identifier:
NCT02073331
First received: February 24, 2014
Last updated: July 25, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)